SRRKScholar Rock Holding Corporation

$5B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$423,000

Operating Income

-$104M

Net Income

-$102M

EPS (Diluted)

$-0.90

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$69M

Free Cash Flow

-$69M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$412M

Total Liabilities

$167M

Stockholders' Equity

$245M

Cash & Equivalents

$287M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$423,000	-$446,000	+5.2%
Operating Income	-$104M	-$65M	-59.8%
Net Income	-$102M	-$64M	-58.5%

SRRK Q3 2025 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena